What is Freed?
Freed operates at the intersection of artificial intelligence and healthcare, providing an AI-powered medical scribe solution designed to alleviate the documentation burden on clinicians. The platform meticulously transcribes patient visits, subsequently extracting, summarizing, and structuring medically relevant information into the appropriate format for electronic health records (EHRs). This innovative approach aims to replicate the efficiency of a human scribe without the extensive training requirements, thereby streamlining administrative tasks and allowing healthcare professionals to focus more on patient care. The company's technology is integrated into clinicians' preferred EHR systems, ensuring seamless adoption and workflow enhancement.
How much funding has Freed raised?
Freed has raised a total of $30M across 1 funding round:
Series A
$30M
Series A (2025): $30M with participation from Scale Venture Partners and Sequoia Capital
Key Investors in Freed
Scale Venture Partners
Scale Venture Partners is an early-stage venture capital firm that invests in founders building category-defining businesses. They provide hands-on consulting and go-to-market advisory from experienced executives to support companies on their journey from founder-led growth to scalable operations. Their portfolio includes notable companies such as DocuSign, HubSpot, and Box, reflecting their commitment to backing innovative startups. The firm focuses on partnering with early-stage AI companies, helping them navigate the challenges of growth and market entry.
Sequoia Capital
Sequoia Capital in India currently manages funds capitalized at close to USD 1.4 billion and invests across venture, growth, and late stage opportunities. It takes a long-term view on investments and plays the role of an active, value-added partner to entrepreneurs, business families and management teams. Over the past 7 years, Sequoia Capital has invested in more than 70 companies in India including Capillary Technologies, Druva Software, Justdial, Micromax, Mu Sigma, Pine Labs, Prizm Payments, Quick Heal and Zomato. Sequoia Capital operates out of offices in Bangalore, Mumbai, and New Delhi. Globally, Sequoia Capital has an unparalleled track record of partnering with entrepreneurs to create global market leaders. Sequoia Capital has been an early investor in companies such as Apple, Cisco, Dropbox, Google, LinkedIn, Oracle, Yahoo, YouTube and Zappos. Sequoia Capital maintains dedicated teams in USA, China, India and Israel.
What's next for Freed?
The recent major enterprise-level funding and strategic investment signal Freed's transition into a scaling phase, likely focusing on expanding its market reach and further developing its AI capabilities. With this substantial backing, Freed is poised to enhance its product offerings, potentially exploring deeper EHR integrations and advanced clinical data analytics. The company's trajectory suggests a strong emphasis on solidifying its position as a leader in AI-driven healthcare documentation solutions, aiming to capture a larger share of the medical scribe market and drive widespread adoption across various clinical settings.
See full Freed company page
